Piskorz D.L.
231
Coauthors
6
Documentos
Volumen de publicaciones por año
Cargando gráfico
Año de publicación | Num. Publicaciones |
---|---|
2014 | 1 |
2017 | 2 |
2020 | 1 |
2021 | 1 |
2022 | 1 |
Publicaciones por áreas de conocimiento
Cargando gráfico
Área de conocimiento | Num. Publicaciones |
---|---|
Medicina interna | 4 |
Enfermedad cardiovascular | 4 |
Diabetes | 1 |
Hipertensión | 1 |
Medicamento | 1 |
Publicaciones por áreas temáticas
Cargando gráfico
Área temática | Num. Publicaciones |
---|---|
Enfermedades | 5 |
Medicina y salud | 5 |
Farmacología y terapéutica | 4 |
Fisiología humana | 1 |
Gestión y servicios auxiliares | 1 |
Principales fuentes de datos
Origen | Num. Publicaciones |
---|---|
Scopus | 6 |
Google Scholar | 3 |
RRAAE | 0 |
Cargando gráfico
Coautores destacados por número de publicaciones
Coautor | Num. Publicaciones |
---|---|
PATRICIO LOPEZ -JARAMILLO | 5 |
Ponte-Negretti C.I. | 4 |
Cobos L. | 3 |
Lorenzatti A.J. | 3 |
Barbosa E.C.D. | 3 |
Puente-Barragan A. | 3 |
Wyss F.S. | 3 |
Lozada A.F. | 2 |
Bryce A. | 2 |
Ullauri V.E. | 2 |
Cargando gráfico
Top Keywords
Cargando gráfico
Publicaciones del autor
Considerations and guidance for the structure, organisation, and operation of cardiometabolic prevention units: A consensus statement of the Inter-American Society of Cardiology
ArticleAbstract: Cardiovascular diseases (CVDs) remain the leading cause of death worldwide, particularly in low- andPalabras claves:Cardiometabolic prevention unit, cardiometabolic risk, Cardiovascular preventionAutores:Barbosa E.C.D., Borrayo G., Cobos L., Gómez-Mancebo J.R., López-Santi R., Lorenzatti A.J., Machado L., PATRICIO LOPEZ -JARAMILLO, Piskorz D.L., Ponte-Negretti C.I., Puente-Barragan A., Ruiz E., Sosa-Liprandi Á., Valdéz O., Wyss F.S.Fuentes:googlescopusPosition statement of the Interamerican Society of Cardiology (IASC) on the current guidelines for the prevention, diagnosis and treatment of arterial hypertension 2017–2020
ArticleAbstract: Objectives: As an Inter-American Society we are convinced of the need to standardize the steps in whPalabras claves:Guidelines, Hypertension, TreatmentAutores:Almonte C., Barbosa E.C.D., Cobos L., Coca A., de la Noval R., Gonzales Medina Á., Iñiguez A., Lanas F.T., Lara-Terán J.J., Parati G., Paris J.V., PATRICIO LOPEZ -JARAMILLO, Perez G., Piskorz D.L., Ponte-Negretti C.I., Puente-Barragan A., Restrepo G., Sebba-Barroso W.K., Sosa-Liprandi Á., Ullauri V.E., Valdéz O., Valoy L.V., Wyss F.S.Fuentes:googlescopusLatin American Consensus on management of residual cardiometabolic risk. A consensus paper prepared by the Latin American Academy for the Study of Lipids and Cardiometabolic Risk (ALALIP) endorsed by the Inter-American Society of Cardiology (IASC), the International Atherosclerosis Society (IAS), and the Pan-American College of Endothelium (PACE)
ArticleAbstract: Background: Hypertension, hyperglycemia, dyslipidemia, overweight, obesity, and tobacco (smoking, chPalabras claves:Atherosclerotic cardiovascular disease, Cardiometabolic risk factors, Cardiovascular Risk, inflammation, Residual risk, ThrombosisAutores:Amaro A.J.J., Badimon J.J., Berrospi P., Bryce A., Cobos S. L., Duran M., Gómez-Mancebo J.R., González J.J.R., Lanas F.T., Lara J., Libby P., Lorenzatti A.J., Lozada A.F., Medina-Palomino F.A., Miranda D., PATRICIO LOPEZ -JARAMILLO, Piskorz D.L., Ponte-Negretti C.I., Puente-Barragan A., Rodrigo A.K., Santos R.D., Toth P.P., Ullauri-Solórzano V.E., Urina-Triana M., Valdés T.O., Villar R., Wyss F.S.Fuentes:scopusAtherogenic Dyslipidemia in Latin America: Prevalence, causes and treatment: Expert's position paper made by The Latin American Academy for the Study of Lipids (ALALIP) Endorsed by the Inter-American Society of Cardiology (IASC), the South American Society of Cardiology (SSC), the Pan-American College of Endothelium (PACE), and the International Atherosclerosis Society (IAS)
ArticleAbstract: This is an executive summary made by a group of experts named Latin American Academy for the study oPalabras claves:Autores:Acevedo M., Alonso R., Arocha I., Bryce A., Carlos Ernesto Peñaherrera, Carrera C., Chirinos J.A., Cobos L., Colan J., Gómez-Alvares E., Gómez-M J.R., Isea-Perez J.E., Lanas F., Lara J., Lorenzatti A.J., Lozada A.F., Machado-H L.T., Medina J., Medina-Palomin F., Merchan-V A., Morales E., Paniagua M., PATRICIO LOPEZ -JARAMILLO, Pinto X., Piskorz D.L., Ponte-Negretti C.I., Ullauri V.E., Varleta P., Villar-M R.A., Wyss-Q F.S.Fuentes:scopusClinical Perspective on Antihypertensive Drug Treatment in Adults With Grade 1 Hypertension and Low-to-Moderate Cardiovascular Risk: An International Expert Consultation
ReviewAbstract: Hypertension is a leading risk factor for disease burden globally. An unresolved question is whetherPalabras claves:Autores:Aguirre-Palacios F., Alcocer L., Barbosa E.C.D., Bertomeu-Martinez V., Bryce-Moncloa A., Burrell L.M., Coca A., Duenas-Herrera A., Kones R., Lanas F., Landrove O., Lavie C.J., Machado C.A., Morales Salinas A., Olsen M.H., Ordunez P., Orias M., Ortellado J., Parra-Carrillo J.Z., PATRICIO LOPEZ -JARAMILLO, Perez G., Pineiro D.J., Piskorz D.L., Prabhakaran D., Ramírez A.J., Redon J., Rodriguez Portelles A., Rodriguez-Leyva D., Sabio R., Sanchez R.A., Schutte A.E., Sebba-Barroso W.K., Sobrino J., Sundström J., Ventura H., Waisman G., Wang J.G., Weber M.A., Yano Y., Yusuf S., Zanchetti A.Fuentes:googlescopus